Chris Sale, now a key arm for the Atlanta Braves, continues to command one of baseball's highest salaries, though his financial landscape has seen some interesting shifts. For the 2024 MLB season, Sale is set to earn a substantial $27.5 million. This significant figure originates from the five-year, $145 million extension he inked with the Boston Red Sox back in March 2019. Following his trade to Atlanta in December 2023, the Red Sox are contributing $17 million of his 2024 salary, with the Braves covering the remaining $10 million. His deal also includes a $20 million club option for the 2025 season.
From Rookie Deal to Ace Money
Sale's journey to becoming a perennial multi-million dollar pitcher illustrates a clear progression for an elite talent. Drafted by the Chicago White Sox in 2010, he initially signed a team-friendly five-year, $32.5 million contract in 2013, which kept him under control through his arbitration-eligible years. His subsequent trade to the Boston Red Sox in 2017 truly elevated his financial standing. After a dominant stretch with Boston, he secured the blockbuster $145 million extension that firmly placed him among the game's highest-paid pitchers, reflecting his status as a Cy Young contender year after year.
Despite recent seasons being impacted by injuries, Sale's current $27.5 million salary still positions him among the top earners for starting pitchers in Major League Baseball. While newer, record-breaking contracts have emerged, his existing deal ensures he remains a highly compensated veteran. When compared to his peers, Sale's earnings reflect his sustained excellence for over a decade. His career trajectory and cumulative earnings underscore the immense value he has brought to multiple organizations, as he now looks to regain his consistent dominance on the mound for the Braves.
Trade on Every Game with Kalshi
Click Here to sign up to Kalshi — Free $10 when you sign up using our link or use code: ONTAPSEA. The only federally regulated prediction market in the US. Trade on real sports outcomes. Available in all 50 states.